2m 2m 2m 2m 2m 2m 2m
Zoetis-A (ZTS)
NYSE
$82.40+$2.78 (+3.49%)
Price as of Oct 22, 2026 8:00 PM EDT- $32.9BMarket Cap
- -44.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Zoetis-A (ZTS)
$82.40+$2.78 (+3.49%)
ZTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $79.62 | ||
Change | -$0.42 (-0.52%) | ||
Open | $79.22 | ||
High | $80.00 | ||
Low | $78.88 | ||
Previous Close | $80.04 | ||
Volume | 3,037,280 | ||
30-Day Average Volume | 4,092,859 | ||
1-Week Change | 5.75% | ||
1-Month Change | 11.62% | ||
1-Year Change | -44.84% | ||
3-Year Change | -50.35% | ||
5-Year Change | -59.63% | ||
Fundamentals | |||
Shares Outstanding | 413.2M | ||
Total Assets | $15.1B | ||
Market Cap | $32.9B | ||
Enterprise Value | $40.5B | ||
Period: QTR TTM FY | |||
Revenue | $2.5B | ||
Net Income | $691.0M | ||
Free Cash Flow | $538.0M | ||
EBIT | $927.0M | ||
EBITDA | $1.0B | ||
Net Working Capital | $4.3B | ||
EPS | $1.65 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 10 | ||
P/E | 48 | ||
PEG | 3 | ||
Price/Free Cash Flow | 61 | ||
Price/Operating Cash Flow | 50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.66% | ||
Trailing Annual Dividend Yield | 2.62% | ||
Ex-Dividend Date | 10/30/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield